VA Federal Supply Schedule Service

Federal Supply Schedule (FSS) contract holder, VA ordering facilities have contacted FSS and requested that we pursue 97 highly purchased items to be added to the FSS. Product addition modifications for Trades Agreement Act (TAA) compliant versions of these items are encouraged. Please follow the normal Product Request for Modification process to submit any new TAA compliant items.

1. Abacavir SO4 600mg/Lamivudine 300mg Tab
2. Acamprosate
3. Acamprosate CA 333mg EC Tab
4. Acamprosate CA 333MG TAB
5. Adapalene 0.1% Gel — Pharmaceutical
6. Alyacen 1/35 TAB,28
7. Amitriptyline HCL 50MG tablet
8. Amlodipine 5mg/Benazepril 20mg Cap
9. Amlodipine 5mg/Benazepril 40mg Cap
10. Amlodipine 10mg/Benazepril 20mg Cap
11. APAP 325MG/Butalbital 50MG/CAFN 40MG TAB
12. Artificial Saliva (Biotene Mouth) Spray
13. Artificial Saliva Oral Spray
14. Azathioprine 50mg tab; Amlodipine 5mg/Benazepril 10mg Cap
15. Bag Leg Conveen #5170
16. Barrier Brava Strips C#120700
17. Breast Milk Storage Bag
18. Budesonide 0.5MG/2ML INH SUSP 2ML
19. Camphor-Menthor-Methyl Salicylate Large Patch
20. Camphor/Menthol/Methyl Salicylate Patch
21. Camphor Menthol Pain Patch
22. Cath Set, Intermit 14FR APOGEE H#B14FB
23. Cefpodoxime Tablets
24. Cetirizine HCL 5MG TAB
25. Clamco Film Reel Holders
26. Clindamycin 1% Topical Solution Pharmaceutical
27. Clindamycin P04 1% TOP SWAB
28. Clindamycin Topical Solution
29. Clomiphene Citrate 50mg Tab
30. Clomiphene Citrate Pharmaceutical
31. Clomiphene Citrate tablets
32. Clonazepam .5MG
33. Clonazepam 1MG
34. Clonazepam 2MG
35. Clonazepam 5MG
36. Clonazepam 10MG
37. Contour Next (Glucose) Test Strip 50CT
38. Contour Next (Glucose) Test Strip 100CT
39. Darifenacin 7.5mg SA Tab
40. Diclofenac NA 25MG EC TAB
41. Eyelid Cleanser, Eye Scrub Pad
42. Eyelid Cleanser Compliance Kit
43. Fenofibrate 145MG TAB
44. Galantamine Hydrobromide 8MG SA CAP
45. Galantamine Hydrobromide 8mg Tab
46. Galantamine Hydrobromide 12MG TAB
47. Galantamine Hydrobromide 16MG SA CAP
48. Glimepiride 4MG
49. Glyburide 5mg/Metformin
50. HCTZ 12.5mg/Valsartan 80mg Tab
51. Irbesartan 300MG
52. Lancet, Onetouch Delica Plus 33G
53. Lansoprazole 15MG SA Disintegrating TAB
54. Lansoprazole 30MG SA Disintegrating TAB
55. Lansoprazole 30MG SA Disintegrating TAB
56. Leg Bag Combination H#9349 LATEX FREE
57. Magnesium Oxide 140 MG Capsule
58. Menthol/M-Salicylate 16-30% Top Cream 85GM
59. Metformin HCL 500MG 24HR SA TAB
60. Metformin HCL 750MG 24HR SA TAB
61. Mineral Oil Enema
62. Mineral Oil, Light/Mineral OIL OPH SOLN
63. Minoxidil 5% TOP SOLN
64. Moisturizer VAG GEL (EQV-REPLENS)
65. Moisturizing Lotion 240 & 480
66. Naphozoline HCL 0.012% POH SOLN
67. Nephro-Vite RX TAB
68. Nevirapine 200MG tab
69. One Touch Ultra (Glucose) Test Strip 100CT
70. One Touch Ultra (Glucose) Test Strip 50CT
71. OneTouch Ultra Glucose Test Strips
72. Ostomy Venting System (OSTO-EZ-VENT)
73. PEG-400 0.4%/PROP GLY 0.3% Eye Drops UD
74. Pentetate Calcium Trisodium and Pentetate Zinc Trisodium — Pharmaceuticals
75. Permethrin 1% TOP Liquid
76. Petrolatum (White) OINT 30GM
77. Polyvinyl Alcohol 1.4% Lubricating Eye Drops
78. Reservoir, T:SLIM 3ML
79. Reservoir, T:SLIM W/T:LOCK,3ML
80. Reservoir T:SLIM X2 W/T:LOCK 3ML
81. Risperidone 0.5MG tab
82. Risperidone 4MG
83. Salicyclic Acid 6% TOP GEL
84. Set Infusion Autosoft XC TANDEM #1001680
85. Set, Infusion Autosoft XC TANDEM #1001681
86. Set, Infusion Minimed #MMT-381A
87. Sodium Chloride 2% OPH SOLN
88. Sumatriptan 6MG/0.5ML INJ Syringe 0.5ML
89. Syringe, Feeding ENFIT 60ML
90. Tamsulosin — Pharmaceutical
91. Timolol Maleate .5% OPH Gel
92. Tobramycin Ophthalmic Solution 0.3% 5mL — Pharmaceutical
93. Verapamil HCL
94. XYLITOL ORAL DISC
95. Zolmitriptan 5MG DISINTEGR TAB PKG 3
96. Zolpidem Tartrate 6.25MG SA TAB
97. Zolpidem Tartrate 12.5MG SA TAB

We are excited to announce that the GSA Sales Reporting Portal (SRP) is live as of April 1, 2024 and you can access the SRP to report sales and remit the Industrial Funding Fee (IFF). Below is some key information:

Historic Sales Data Migration

• GSA/VA has successfully migrated over all historical data under the VA FSS program. The historical contract data previously stored in the legacy VA Sales Reporting System now resides in the new SRP.
• This will allow you to access your past sales records, make adjustments to previous sales reports, and submit reports for any previously unreported quarters.

IFF Credits and Debit Balances

• The SRP will reflect any positive or negative Industrial Funding Fee (IFF) due balance over the life of your contract.
  • Positive balances (credits) will be automatically applied against future IFF due balances.
  • Negative or past due balances (debits) will be presented for resolution when submitting subsequent sales reports in the system.
• Important: If you believe any credit/debit balance shown is incorrect, please reach out to your assigned Contract Specialist (CS) for further assistance.

Technical Assistance

• VA Specific user guides are provided on the FAS SRP page (in the upper right-hand corner, under “Help” | “VA Online Help”). This includes step-by-step guidance on how to create your account and login, as well as how to report data, adjust data, and submit payments.
• For technical assistance related to the new SRP, please contact the GSA Vendor Support Center:
  • Phone: 1-877-495-4849
  • Email: Vendor.Support@gsa.gov
• Lastly, if for any reason you do not see your contract on your home screen after login or have any issues with payments, please reach out to your assigned Contract Specialist (CS) or FSSSAles@va.gov to request additional assistance.

Frequently Asked Questions

1. Why is VA moving sales reporting to GSAs FAS Sales Reporting Portal (SRP)?
   VA FSS is transitioning the reporting of sales and remittance of the IFF over to the new GSA’s FAS Sales Reporting Portal. This will standardize GSA and VA sales reporting processes by using the same modernized IT infrastructure that will simplify sales reporting and IFF payment process. The goal of this transition is to provide a streamlined process under one robust and modern system.
2. Will contractors have to report monthly sales data in the FAS Sales Reporting Portal?
   No, VA FSS contractors will still report sales and remit IFF on a quarterly basis. The only difference is they will be reporting sales in the FAS Sales Reporting Portal rather than in the VA Sales Reporting System.
3. Will only authorized points of contact listed on the VA contract have access to the FAS Sales Reporting Portal?
   Yes, The FAS Sales Reporting Portal supports role-based access as one of its features. In addition to individual authentication and authorization, VA FSS users are assigned specific roles and permissions, which allow the user to perform very specific actions within the system.
4. Where do I go for help once the transition has taken place?
   Contact the GSA Vendor Support Center help desk for technical assistance
   Vendor Support Center
   Tel: 877-495-4849
   Email: vendor.support@gsa.gov
5. How can I view the new FAS Sales Reporting Portal System prior to the transition?
   You can watch the short tutorial videos posted at the FAS SRP Training site. This will give you a great head start and look into the new system. Note that only the quarterly applications will apply to VA FSS.
6. How can I prepare for this transition?
   The VA will be sending out emails to contractors that hold Federal Supply Schedules contracts. The emails will explain the process and what needs to take place as we transition from one system to the other. The best way to prepare for this transition would be to make sure all your POC’s listed on your contract are up to date and accurate. This can be accomplished by reaching out to your Contracting Officer to confirm the POC information and then submitting any required documentation to make any necessary changes.
7. Will all of my data flow over to the new FAS Sales Reporting Portal?
   Yes, all of the past data will be transitioned over to the new FAS Sales Reporting Portal and will be visible over the coming months. This transition of historical data will happen after the final sales are reported and IFF remitted in the legacy VA Sales Reporting System. Please make sure sales reporting is kept current during calendar year 2023-2024 so that sales information can be transferred in a timely manner.
8. After the transition, how can contractors adjust sales which were reported in the legacy VA Sales Reporting System?
   Contractors will be able to adjust quarterly sales for past reporting periods in the FAS Sales Reporting Portal once the historical data has been migrated. Reminder, no quarter is exempt from sales reporting, even zero sales must be reported for the applicable quarter.

Per our first notification in March, you were informed that VA FSS will be transitioning the sales reporting and IFF remittance process from the legacy VA Sales Reporting System to GSA’s Federal Acquisition Service (FAS) FAS Sales Reporting Portal (SRP) by the end of CY23.

As part of the upcoming transition, and to align our practices with GSA, we will be shortening the deadline for reporting sales outlined in clause 552.238-80 Industrial Funding Fee and Sales Reporting from 60 to 30 days. Currently VA FSS uses a tailored version of this clause in which we lengthened the reporting time period to 60 days from 30 days (standard clause version).

Read the revised clause

As this may require adjustments to your internal business operating practices, this advance notice is provided for you to begin preparations for transitioning to the shorter reporting period. The new clause language will be issued via mass modification in late CY23 and take effect on January 1, 2024, coinciding with the transition to the FAS SRP system. You do not have to wait for the new clause language to transition and begin reporting within 30 days after the close of the quarter.

Recommended Action: Please assess the implications of this change and begin preparation to fundamentally change or tweak your internal processes so that you can comfortably achieve Sales report filing and IFF remittance for Quarter 1 of FY 2024 and all subsequent quarters within 30 days after the close of the quarter.

Background: Quest Diagnostics has developed (laboratory developed test LDT) a molecular diagnostic test that aids in the diagnosis of infection of monkeypox virus in submitted specimens. This novel dual target test employs polymerase chain reaction (PCR) to aid in the qualitative detection of non-variola orthopoxviruses and monkeypox virus (West African clade) DNA, using swab specimens from patients presenting with an acute pustular or vesicular rash.

Delivery/Production Capacity:Quest expects to be able to perform approximately 30,000 Monkeypox virus tests a week. Depending on demand, the company can expand capacity for Monkeypox testing across other advanced laboratories within its national network.

Ordering Information: LeeAnn Bocklet - (804) 306-0913

Veterans Affairs: Normal ordering procedures are in effect.

Other Government Agencies (Federal): Please follow established local procedures.

Visit the NAC Contract Catalog Search Tool to view contract information. We will continue to work with our industry partners to add more Monkeypox tests to the FSS as expeditiously as possible. We will keep you apprised of any future updates. Please contact our FSS Helpdesk if you have any questions.

/s/Daniel H. Shearer
Director, VA Federal Supply Schedule Service